Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection
Background: Heart transplantation remains the gold standard for end-stage heart failure, with current ex vivo organ storage times limited to 4 to 6 h before critical tissue damage occurs. Many preservation solutions exist in an attempt to limit both ischemic and reperfusion damage. In order to compa...
Main Authors: | , , , , , |
---|---|
Other Authors: | |
Language: | en |
Published: |
BIOMED CENTRAL LTD
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/622950 http://arizona.openrepository.com/arizona/handle/10150/622950 |
id |
ndltd-arizona.edu-oai-arizona.openrepository.com-10150-622950 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-arizona.edu-oai-arizona.openrepository.com-10150-6229502017-04-01T03:00:38Z Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection Ferng, Alice S. Schipper, David Connell, Alana M. Marsh, Katherine M. Knapp, Shannon Khalpey, Zain Univ Arizona, Coll Med, Dept Surg, Div Cardiothorac Surg Univ Arizona, Coll Med, Dept Physiol Sci Univ Arizona, Coll Med, Dept Biomed Engn Univ Arizona, Coll Med Univ Arizona, Coll Med, BIOS Inst, Stat Consulting Lab Organ preservation solution Cardiac myoblasts Mitochondria Bioenergetics Somah Celsior Perfadex Background: Heart transplantation remains the gold standard for end-stage heart failure, with current ex vivo organ storage times limited to 4 to 6 h before critical tissue damage occurs. Many preservation solutions exist in an attempt to limit both ischemic and reperfusion damage. In order to compare the effects of various storage solutions, mitochondrial function can be used to provide a sensitive analysis of cellular metabolic function. Methods: Experimental plates were seeded with cardiac myoblasts and kept in suspended animation for either 4 or 8 h at either 4(o) or 21 degrees C, in Celsior (R), Perfadex (R), or Somah storage solutions. Cells were then reanimated for 1 h at 37 degrees C to simulate a reperfusion or clinical transplant scenario. Cellular bioenergetics were measured immediately thereafter to examine biochemical differences between preservation solutions and their effectiveness on preserving metabolic function. Results: The oxygen consumption rates of Somah solution were significantly higher than Celsior (R) and Perfadex (R) at 4 degrees C, with the exception of Perfadex (R) at 4(o) for 4 h. This effect was sustained up to 8 h. At 21 degrees C, oxygen consumption rates of Somah solution are significantly higher than Celsior (R) and Perfadex (R) at basal conditions after 4 h, but this effect is not sustained after 8 h. Conclusions: The purpose of this experiment was to study the efficacy of various preservation solutions on a mitochondrial level. The significantly higher oxygen consumption rates of Somah at 4 degrees C suggests that Somah solution may have the ability to protect cellular mitochondrial integrity, improve transplanted organ function by reducing ischemic-reperfusion injury, and thereby improve transplant outcomes. Given that Somah offers benefits over Celsior (R) and Perfadex (R) at 4 degrees C, it should be a target in future organ preservation solution research. 2017-01-26 Article Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection 2017, 12 (1) Journal of Cardiothoracic Surgery 1749-8090 28126002 10.1186/s13019-017-0564-x http://hdl.handle.net/10150/622950 http://arizona.openrepository.com/arizona/handle/10150/622950 Journal of Cardiothoracic Surgery en http://cardiothoracicsurgery.biomedcentral.com/articles/10.1186/s13019-017-0564-x © The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 BIOMED CENTRAL LTD |
collection |
NDLTD |
language |
en |
sources |
NDLTD |
topic |
Organ preservation solution Cardiac myoblasts Mitochondria Bioenergetics Somah Celsior Perfadex |
spellingShingle |
Organ preservation solution Cardiac myoblasts Mitochondria Bioenergetics Somah Celsior Perfadex Ferng, Alice S. Schipper, David Connell, Alana M. Marsh, Katherine M. Knapp, Shannon Khalpey, Zain Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection |
description |
Background: Heart transplantation remains the gold standard for end-stage heart failure, with current ex vivo organ storage times limited to 4 to 6 h before critical tissue damage occurs. Many preservation solutions exist in an attempt to limit both ischemic and reperfusion damage. In order to compare the effects of various storage solutions, mitochondrial function can be used to provide a sensitive analysis of cellular metabolic function. Methods: Experimental plates were seeded with cardiac myoblasts and kept in suspended animation for either 4 or 8 h at either 4(o) or 21 degrees C, in Celsior (R), Perfadex (R), or Somah storage solutions. Cells were then reanimated for 1 h at 37 degrees C to simulate a reperfusion or clinical transplant scenario. Cellular bioenergetics were measured immediately thereafter to examine biochemical differences between preservation solutions and their effectiveness on preserving metabolic function. Results: The oxygen consumption rates of Somah solution were significantly higher than Celsior (R) and Perfadex (R) at 4 degrees C, with the exception of Perfadex (R) at 4(o) for 4 h. This effect was sustained up to 8 h. At 21 degrees C, oxygen consumption rates of Somah solution are significantly higher than Celsior (R) and Perfadex (R) at basal conditions after 4 h, but this effect is not sustained after 8 h. Conclusions: The purpose of this experiment was to study the efficacy of various preservation solutions on a mitochondrial level. The significantly higher oxygen consumption rates of Somah at 4 degrees C suggests that Somah solution may have the ability to protect cellular mitochondrial integrity, improve transplanted organ function by reducing ischemic-reperfusion injury, and thereby improve transplant outcomes. Given that Somah offers benefits over Celsior (R) and Perfadex (R) at 4 degrees C, it should be a target in future organ preservation solution research. |
author2 |
Univ Arizona, Coll Med, Dept Surg, Div Cardiothorac Surg |
author_facet |
Univ Arizona, Coll Med, Dept Surg, Div Cardiothorac Surg Ferng, Alice S. Schipper, David Connell, Alana M. Marsh, Katherine M. Knapp, Shannon Khalpey, Zain |
author |
Ferng, Alice S. Schipper, David Connell, Alana M. Marsh, Katherine M. Knapp, Shannon Khalpey, Zain |
author_sort |
Ferng, Alice S. |
title |
Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection |
title_short |
Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection |
title_full |
Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection |
title_fullStr |
Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection |
title_full_unstemmed |
Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection |
title_sort |
novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection |
publisher |
BIOMED CENTRAL LTD |
publishDate |
2017 |
url |
http://hdl.handle.net/10150/622950 http://arizona.openrepository.com/arizona/handle/10150/622950 |
work_keys_str_mv |
AT ferngalices novelvsclinicalorganpreservationsolutionsimprovedcardiacmitochondrialprotection AT schipperdavid novelvsclinicalorganpreservationsolutionsimprovedcardiacmitochondrialprotection AT connellalanam novelvsclinicalorganpreservationsolutionsimprovedcardiacmitochondrialprotection AT marshkatherinem novelvsclinicalorganpreservationsolutionsimprovedcardiacmitochondrialprotection AT knappshannon novelvsclinicalorganpreservationsolutionsimprovedcardiacmitochondrialprotection AT khalpeyzain novelvsclinicalorganpreservationsolutionsimprovedcardiacmitochondrialprotection |
_version_ |
1718436034860023808 |